Pediatric oncologists' perspectives on the use of complementary medicine in pediatric cancer patients in Switzerland: A national survey‐based cross‐sectional study
Léopold Pirson(University of Geneva), André O. von Bueren(University of Geneva), Katrin Scheinemann(University of Lucerne), Manuel Diezi(Centre Hospitalier Universitaire Vaudois), Pierluigi Brazzola, Sabine Kroiss(University Medical Center Freiburg), Nicolas von der Weid(University of Basel), Freimut H. Schilling(Olgahospital), Jeanette Greiner(Ostschweizer Kinderspital), Sonja Lüer(University Hospital of Bern), Tycho Jan Zuzak(Gemeinschaftskrankenhaus Herdecke)
Cited by 8
Related Papers
Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations
|Nature Genetics|2014|659
Subgroup-Specific Prognostic Implications of <i>TP53</i> Mutation in Medulloblastoma
|Journal of Clinical Oncology|2013|488
Immunohistochemical analysis of H3K27me3 demonstrates global reduction in group-A childhood posterior fossa ependymoma and is a powerful predictor of outcome
|Acta Neuropathologica|2017|251
<i>BRAF-KIAA1549</i> Fusion Predicts Better Clinical Outcome in Pediatric Low-Grade Astrocytoma
|Clinical Cancer Research|2011|244
Phase II Weekly Vinblastine for Chemotherapy-Naïve Children With Progressive Low-Grade Glioma: A Canadian Pediatric Brain Tumor Consortium Study
|Journal of Clinical Oncology|2016|243